13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001664974
Total reported value
$78.6M
$78.6M
6 檔
288.0%
As reported in its official Q4 2024 Form 13F filing, Data Collective IV GP, LLC's tracked investment portfolio stood at $78.6M with 6 total positions.
In Q4 2024, Data Collective IV GP, LLC adopted a defensive or profit-taking posture, trimming 2 positions and completely liquidating 0 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | OKLO | Oklo Inc | Stock-Utilities | 49.51% | — | -23.74% | |
| 2 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 17.75% | -4.84% | — | |
| 3 | EVLV | Evolv Technologies Holdings | Stock-Other | 16.90% | -15.74% | — | |
| 4 | RKLB | Rocket Lab Corporation | Stock-Industrials | 15.51% | — | -52.96% | |
| 5 | BRD1EUR | Mind Medicine Mindmed Inc | Stock-Other | 0.31% | — | — | |
| 6 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 0.02% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | OKLO | Oklo Inc | +15.3% | -23.74% | Trim |
| 2 | ROIV | Roivant Sciences Ltd. | 0% | — | Unchanged |
| 3 | BRD1EUR | Mind Medicine Mindmed Inc | 0% | — | Unchanged |
| 4 | RKLB | Rocket Lab Corporation | -1.9% | -52.96% | Trim |
| 5 | RXRX | Recursion Pharmaceuticals-a | -6.2% | — | Unchanged |
| 6 | EVLV | Evolv Technologies Holdings | -7.1% | — | Unchanged |
According to official SEC Form 13F filings, Data Collective IV GP, LLC reported a total U.S. public equity portfolio value of $78.6M across 6 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including OKLO, RXRX, EVLV) accounted for 288.0% of total reported equity market value during Q4 2024.
Top Position Liquidated / Trimmed
OKLO
前期市值: $56.0M
During Q4 2024, Data Collective IV GP, LLC's top holdings by market value included OKLO (49.5%)、RXRX (17.8%)、EVLV (16.9%). The largest single position, OKLO, represented 49.5% of total portfolio value.
In Q4 2024, Data Collective IV GP, LLC made 2 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 2 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.